title: Few options available for arthritis pain relief. FDA declines to approve Merck's Arcoxia.
authors.forename: Donna
authors.initials: D
authors.lastname: Young
mesh_terms: D001168:Arthritis / Q000188:drug therapy*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D000077613:Etoricoxib; D006801:Humans; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D013450:Sulfones / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib